reSee.it - Related Video Feed

The speaker emphasizes the lengthy process of developing a safe and effective vaccine, usually taking 10 to 25 years. They mention a potential safety issue with coronavirus vaccines, where immunization may lead to immune enhancement when exposed to the virus. This phenomenon has been observed in laboratory animals. Despite this concern, the speaker expresses enthusiasm for the approval of the second vaccine, stating that if enough Americans get vaccinated, virus transmission could be halted. They also mention the availability of new boosters, recommending anyone who is safe to get them for added protection.

As a scientist, it's important to be criticized and hold science to a high standard. However, this doesn't work well in the public health arena. The example of the bivalent vaccine showed that it wasn't any better than the previous vaccine due to the original antigenic sin problem. Public health officials kept pushing it as better, causing a divisive climate. The recent recommendation for boosters also sparked controversy, as the United States recommends it for everyone over 6 months, while other countries have targeted recommendations for high-risk groups. Nuanced messages get lost in the current climate, but it's important to explain recommendations carefully to the public.

Biden wants as many people as possible to get an annual COVID vaccine. The speaker claims that drug, food, and vaccine companies pay reviewers to approve their products. They believe that if everyone is required to get an annual vaccine, it will bring recurring money to these companies. Christopher Cole, an executive officer at the FDA, says the approval process for the vaccines will be gradual and eventually become an annual requirement like the flu shot. The speaker admits they don't completely agree with the process, especially for toddlers, as there may not be enough testing. However, all age groups are approved under emergency authorization, with the focus on the benefits outweighing the harm. The approval process for toddlers is related to COVID.

Vaccines are seen as magical but expectations should be tempered. Pfizer's vaccine is 95% effective, but efficacy drops over time. Boosters may be needed annually. Moderna is working on a combined flu and COVID vaccine. The future is uncertain, but we must adapt.

Twenty percent of Americans did not take the COVID vaccine because it was not safe enough. The mRNA in the Pfizer and Moderna vaccines has been chemically modified to resist breakdown by enzymes. The mRNA and spike protein are found in the heart and brain, and the spike protein circulates in the blood for six to nine months post-vaccination. The speaker claims the lethal part of the virus circulates in the blood of vaccinated individuals, especially after boosters, and that it is a killer protein. The speaker asserts safety trumps efficacy and objects to claims that vaccines, specifically the COVID-19 vaccine, saved millions of lives. They state that consent forms do not guarantee the vaccine will save lives and that there has never been a prospective, randomized, double-blind, placebo-controlled trial showing that COVID-19 vaccines reduce mortality or hospitalization.

The speaker discusses the question of vaccinating children aged 5-11 against COVID-19. The professor argues in favor of vaccinating them, citing the need to protect children who may require intensive care. However, the other speaker clarifies that currently, there are only 10 children aged 0-9 and 2 children aged 10-19 in intensive care, far from the hundreds mentioned. Even during the peak of the pandemic, there were only 48 children in intensive care out of 7,000 patients. The professor also claims that half the world is vaccinating children aged 5-11, but the other speaker refutes this, stating that while several countries have started vaccinating this age group, they remain a minority. Israel, for example, only recently opened vaccination for this age group due to a lack of sufficient data on the benefits and risks.

The United States government has spread misinformation during the pandemic, including about COVID transmission, vaccine immunity, and mask effectiveness. The Cochrane review, a trusted medical evidence body, contradicts these claims. Myocarditis is more common after vaccination than infection, but young people may benefit from boosters. Top vaccine experts resigned from the FDA over pushing boosters for healthy young individuals without sufficient data. The CDC has manipulated research to fit their agenda, like cherry-picking data on natural immunity. This misuse of medical research is concerning.

Dr. Menares and an interlocutor debate the science behind pediatric COVID vaccination and routine immunizations, focusing on transmission, hospitalization, and risk. - The interlocutor asks whether the COVID vaccine prevents transmission. Speaker 1 answer: the vaccine can reduce viral load in individuals who are infected, and with reduced viral load, there is reduced transmission. The interlocutor reframes, insisting that the vaccine does not prevent transmission and notes decreasing effectiveness over time, citing Omicron data showing around 16% reduction when there is a reduction. - On hospitalization for children 18 and under: Speaker 0 asserts the vaccine does not reduce hospitalization for 18-year-olds; statistics are inconclusive due to small numbers of hospitalizations in that age group (approximately 76 million people aged 18 in the country, with 183 deaths and a few thousand hospitalizations in 2020–2021; numbers have since dropped). The argument emphasizes a need to discuss the issue. - On death for children 18 and under: Speaker 0 says the vaccine does not reduce the death rate; claims there is no statistical evidence that it reduces deaths. Speaker 1 responds with a more cautious stance: “It can,” but Speaker 0 counters, calling that an insufficient answer. - The discussion references the vaccine approval process and ongoing debates in vaccine committees. The interlocutor states that when the vaccine was approved for six months and older, the discussion acknowledged no proof of reduction in hospitalization or death. The argument asserts that the justification for vaccination is based on antibody generation rather than clear hospitalization/death data. The interlocutor contends that immunology measurements (antibody production) do not necessarily justify vaccination frequency. - The core debate centers on what the science supports for vaccinating six-month-olds and the benefits versus risks. The interlocutor argues there is no hospitalization or death benefit for vaccination in this age group, and notes a known risk of myocarditis in younger populations, estimated somewhere between six and ten per ten thousand, which the interlocutor claims is greater than the risk of hospitalization or death being measurable. - The exchange then shifts to changing the childhood vaccine schedule, particularly the hepatitis B vaccine given to newborns when the mother is not hepatitis B positive. The interlocutor asks for the medical or scientific reason to give a hepatitis B vaccine to a newborn with an uninfected mother, arguing that the discussion should focus on whether to change the schedule rather than declaring all vaccines as good or bad. - Speaker 1 says they agreed with considering the science and would not pre-commit to approving all ACIP recommendations without the science. Speaker 0 disagrees, asserting their position that the debate should center on the medical rationale for these specific vaccines and schedules, not on a blanket endorsement of vaccines. - Throughout, the dialogue emphasizes examining the medical reasons and evidence for specific vaccines and schedules, rather than broad generalizations about vaccines.

One in thirty-five recipients of the booster vaccine had vaccine-associated myocardial injury. This level of adverse reaction is described as off the scale in healthcare. The speaker suggests that promoting the vaccine in places like New Zealand is unethical. The speaker believes this risk level would only be acceptable if the alternative was certain death, and otherwise, it is complete madness.

Vaccine recommendations typically come from the Advisory Committee of Immunization Practices (an outside consulting committee at CDC) and VRBPAC (within FDA), which recommends vaccine licensure. These committees only adopted evidence-based medicine about twelve years ago. The speaker states that during their administration, they want safety studies prior to vaccine licensure and recommendation. They claim vaccines are exempt from pre-licensing safety testing, and the COVID vaccine was the only one tested in a full placebo trial. They assert that the other 76 shots children receive between birth and 18 have not been safety tested against a placebo, meaning the risk profile is not understood. The speaker intends to remedy this.

Vaccines have a place, but the population has been scared into accepting them. It's frustrating that vaccines are being promoted as gene therapy to children who are not at risk. It's ethically questionable to recommend something dangerous to a certain group to protect the elderly. Personally, as a 70-year-old, I don't want young people getting vaccinated for my sake. If something happened to them, I would feel guilty.

A discussion takes place about the risk assessment for a teenage male who has had COVID and is considering getting vaccinated. The speakers agree that it is not a fair risk assessment to ignore the previous COVID infection and just keep vaccinating. They mention that if a person is healthy and under 75 years old, having received three doses of an mRNA vaccine or two doses of the vaccine plus a natural infection may provide sufficient protection against severe disease for years. They also mention that some colleges and universities still have mandates for booster doses before allowing students back on campus.

The speaker asks if there is a higher incidence of myocarditis among adolescent males aged 16 to 24 after taking the vaccine. The other speaker responds by saying that the data from the CDC shows that there is actually less myocarditis in people who get the vaccine compared to those who get COVID. The first speaker disagrees and presents six peer-reviewed papers that contradict this claim. They also mention speaking with the president who privately acknowledged the increased risk of myocarditis. The conversation then shifts to discussing the rationality of mandating three vaccines for adolescent boys and the timing of myocarditis after the second dose. The first speaker criticizes the CDC's recommendation to vaccinate individuals who have recovered from COVID and experienced myocarditis. They argue that many countries do not offer the vaccine to children unless they are at risk for severe disease. The first speaker concludes by stating that the risk and benefits of vaccination need to be weighed, and that parents are unlikely to comply with mandatory vaccination for their children.

The question asked whether the president believes the COVID vaccine should be available to and covered by insurance for all Americans regardless of age and preexisting conditions. The response notes that the FDA recently revoked the emergency youth authorizations for three COVID vaccinations while simultaneously approving four new COVID-19 vaccines with 2025 and 2026 formulas. The revocation is described as a consequence of the COVID-19 pandemic and the public health emergency being over. To correct the record, it is stated that the FDA’s decision does not affect the availability of COVID vaccines for Americans who want them. The administration says, “We believe in individual choice,” a promise the president and the secretary have made and delivered on.

The Florida Department of Health, under Surgeon General Dr. Joseph Ladipo, published guidance on updated COVID-19 boosters. On August 22, 2024, the FDA approved updated mRNA vaccines from Pfizer/BioNTech and Moderna for ages 12+ and granted emergency use authorization for ages 6 months to 11 years. The guidance states the booster approval occurred without human clinical trial data and does not protect against the dominant strain, which accounts for 37% of US infections. There is limited data showing substantial protection against the virus or variants. The federal government hasn't required manufacturers to prove boosters prevent hospitalization or death, and has failed to provide sufficient safety and efficacy data or acknowledge safety concerns, including prolonged mRNA/spike protein circulation, increased risk of lower respiratory infections, and increased risk of autoimmune disease. The Florida Department of Health encourages healthcare providers to discuss this guidance with patients. Based on global immunity and available data, Dr. Ladipo advises against mRNA COVID vaccines. Providers concerned about high-risk patients should prioritize non-mRNA vaccines and treatments.

The transcript presents a critical examination of Bill Gates, portraying him as transforming from a software magnate into a global health power broker whose wealth and influence have reshaped public health, vaccine development, and population policy. It argues that Gates’ philanthropic activities are not purely charitable but are deployed to extend control over health systems, global research agendas, and even the reproductive choices of people worldwide. Key claims and points are detailed across several strands: - Public image and power shift: Bill Gates is described as no longer a “public health expert” yet becoming a central figure in billions of lives, guiding medical actions and vaccine strategies. The program asserts that Gates’ reinvention through the Bill and Melinda Gates Foundation has been aided by a sophisticated public relations apparatus and by directing media coverage of global health issues. - Foundation scale and reach: The Gates Foundation is depicted as the world’s largest private foundation, with assets reported as tens of billions of dollars and a broad remit in global health, development, growth, and policy advocacy. Its influence extends to funding media outlets, think tanks, and reporting units across multiple outlets (BBC, NPR, Our World in Data, ABC, among others), creating what the program calls “tentacles” across global health. - Partnerships and funding of global health initiatives: Gates is credited with initiating and funding major global health vehicles, including: - Gavi, the Vaccine Alliance, with seed funding and ongoing commitments that have shaped vaccination markets. - The Global Fund to Fight AIDS, Tuberculosis, and Malaria, and other public-private partnerships that coordinate vaccine development and immunization programs. - Support for CEPI (Coalition for Epidemic Preparedness Innovations), the World Health Organization’s vaccine initiatives, and other pandemic preparedness efforts. - The World Health Organization’s funding profile, described as heavily dependent on Gates Foundation support, with Tedros Adhanom Ghebreyesus noted as a non-medical doctor connected to Gates-backed initiatives. - The “Decade of Vaccines” and vaccine policy: Gates is credited with launching a decade-long vaccine initiative, including a pledge of billions of dollars to vaccine development and distribution. This is linked to the creation of a global vaccine action plan and to Gavi’s role in establishing vaccine markets. The narrative asserts that vaccines have been used to steer global health policy and to secure roles for private firms in public health decision-making. - Vaccine development concerns: The program raises concerns about the safety and speed of vaccine development, criticizing the eighteen-month timeline Gates advocates for a universal vaccine, and questioning the use of new technologies (DNA and mRNA platforms) and rapid deployment with limited testing. It highlights potential safety risks, including historical vaccine-associated disease enhancement and concerns about broad immunization in a short period. - Vaccine safety and regulation: It is claimed that vaccine safety at scale is hard to guarantee and that liability protections for vaccine makers and public health officials have been enacted (e.g., a U.S. declaration granting liability immunity for COVID-19 countermeasures), a point framed as enabling risk-bearing without accountability. - Population control framing: A central thread is the assertion that Gates seeks to reduce population growth through health improvements, vaccines, and reproductive health services. The transcript traces Gates’ interest in contraception and population issues to his family background and to Rockefeller-era eugenics historical contexts, arguing that discussions about fertility, contraceptive technologies, and demographic trends have long-term population implications. It cites specific Gates Foundation activities in reproductive health, including funding for innovative birth-control delivery methods, depot injections, implanted devices, and efforts to develop digital identity tied to health services as tools within a broader population-control framework. - Digital identity and biometric ID: The narrative emphasizes Gates’ involvement with biometric identification through Gavi and ID2020, noting partnerships with Microsoft and the Rockefeller Foundation, the Aadhaar system in India, and the World Bank’s ID4D initiative. It argues that vaccination programs, biometric identity, and cashless payments are being integrated into a comprehensive “population control grid,” enabling state and private actors to track, truncate, or deny access to services based on identity and health status. - Data, surveillance, and privacy concerns: The piece contends that the push for digital IDs, digital health records, and biometrics will erode privacy and enable broad government and corporate surveillance, linking health data to financial services, voting, housing, and welfare. It highlights projects involving digital certificates, immunity passports, and real-time health data collection via microneedle patches and barcode-like skin markers, suggesting these innovations could be used to control access to services. - Epstein connections and broader conspiracy context: The program references alleged connections between Gates and Jeffrey Epstein, including flight logs and involvement in philanthropic funding discussions, framing these ties as part of a broader pattern of influence. It also points to prior associations with notable figures (Buffett, Rockefeller, Soros) and critiques of Gates as aligning with a “population control” ideology. - The underlying motive and conclusion: Throughout, the narrative asserts that Gates’ wealth is being used not for charity alone but to build an overarching system of control—over health institutions, research funding, public policy, identification, and financial systems. It contrasts his public image as a generous philanthropist with alleged hidden agendas, suggesting that the real aim is to shape global governance and human behavior through vaccination, identification, and digital infrastructure. - Final framing and call to action: The closing sections urge viewers to recognize Gates’ influence as part of an ideology rather than a single person’s plan. It frames the situation as a broader movement that could continue beyond Gates personally, urging awareness and action to resist what the program deems a population-control regime embedded in global health and digital identity initiatives. In sum, the transcript portrays Bill Gates as a central figure driving a multifaceted, globally interconnected program—through the Gates Foundation, Gavi, CEPI, and related partnerships—that allegedly reconfigures vaccine policy, global health governance, reproductive health, biometric identification, and digital payments into a cohesive system of population control and surveillance, using philanthropy as a veneer for power and control.

The speakers discuss the need for vaccines to combat the spread of the virus. They mention that traditional vaccines require booster shots to increase protection over time, but it is uncertain if the same applies to the RNA vaccines. They mention the possibility of a fourth dose and the uncertainty surrounding the duration of immunity. They acknowledge that the situation with the virus is unique and express a tolerance for doubts and questions.

The speaker states they searched for years for a pre-licensing safety trial of the 72 vaccine doses effectively mandated for American children. They claim that every other medication requires a safety trial comparing health outcomes in a placebo group versus a vaccine group before FDA licensing. The speaker assumed this was also done for vaccines. They state they found out that vaccines were exempt from this requirement.

Senator Sanders pressed Secretary Kennedy on booster eligibility, asking if all adults and children over six months are eligible to get a COVID booster at pharmacy. Kennedy: 'Anybody can get the booster.' Sanders noted it is 'not recommended for healthy people' and argued that changing the classification could deny access; Kennedy said, 'We're not gonna recommend a product for which there's no clinical data for that indication.' Sanders warned the policy would 'take away vaccines from anyone who wanted them,' while Kennedy replied, 'I'm not taking them away from people,' and added, 'Most Americans will be able to get it from a pharmacy for free.' 'And first up is ratifying your COVID actions. Second is hepatitis b is on the agenda.' Kennedy: 'I'm not taking vaccines away from anybody.' Later, Kennedy said, 'No. I told her that she had to resign because I asked her, are you a trustworthy person?'

Initially, all vaccines released under emergency use authorization by the FDA were considered outstanding. The J&J vaccine carries a risk of life-threatening blood clots. Despite claims that COVID poses zero threat to healthy children, vaccination for children was urged. Two mRNA vaccines were considered a three-dose vaccine. Two doses were found to be insufficient for emergency room visits and hospitalizations, necessitating a third immunization. A fourth immunization was suggested as a potential innovative solution. The numbers are trending up again, so a new bivalent booster is recommended for everyone ages 12 and older. Those over 50 who have had two boosters more than 2-4 months prior may need a third booster, a fifth immunization. Boosters may not be holding up as well as desired, potentially requiring boosters every few months. Disinformation campaigns have promoted fake concepts of herd immunity and discredited masks. Vaccinating is considered our last hope. The single most impactful thing is to be fully boosted, preferably twice boosted. Monkeypox is accelerating among men who have sex with men, though sources disagree on whether it is sexually transmitted.

The CDC has recommended COVID vaccines for everyone over the age of 6 months, which contradicts the UK's recommendation for those over 65. The CDC's communication does not mention the vaccines being safe and effective. They provide some data on the estimated risk of hospitalizations prevented per 1,000,000 doses, but there is limited information on adverse reactions. The speaker questions the CDC's thinking and highlights the high number of adverse reactions compared to the number of hospitalizations prevented. They also mention the increase in the price of COVID vaccines and raise concerns about the independence and trustworthiness of drug regulators. The symptoms of COVID are similar to those of a common cold for most people.

Speaker 1 states that no vaccines, including the COVID vaccine, have been properly tested. They claim that no childhood vaccine has undergone a placebo-controlled clinical trial of sufficient duration and power to assess its safety before being injected into millions of children in America. Speaker 1 asserts this is not an opinion, but can be verified by anyone reviewing package inserts and clinical trial documents on the FDA website.

As a vaccine researcher, the speaker opposed COVID boosters from the start, based on the principle that vaccines shouldn't require them. Boosters were given because antibody levels fell off, which the speaker says is normal. The speaker claims the booster was a waste of time because it targeted a virus that no longer existed. The speaker alleges the booster suppressed the T cell system and switched antibodies to be tolerizing, increasing the risk of COVID and other infections. The speaker claims to have observed cancer patients relapsing after boosters, despite advising against them. The speaker says they were silenced for raising concerns, but now "everybody knows the truth" that these observations were correct. The speaker cites a Japanese study correlating increased cancer incidence with the vaccine program and expresses alarm that the study was based on deaths. The speaker says data from around the world shows how boosters can suppress immune response and drive cancers. The speaker concludes by lamenting that clinicians and scientists were silenced and unable to make a difference.

Repeated vaccinations can weaken the immune system by building tolerance and shifting protection away from viruses and cancer. This antigen exposure from vaccines can lead to a loss of protection against other viruses and cancer. It is important to note that there has never been a vaccine that requires people to take it every six months indefinitely, which raises concerns.

The first speaker argues that messenger RNA vaccines were unprecedented compared to anything previously developed. They state there was never any justification given for not using a traditional vaccine, and there was never any evidence that the messenger RNA vaccine was as good as a ground-up virus—the old-fashioned type of vaccine—whose safety, efficiency, and cost are well known. They emphasize the importance of that point and note that a recent Korean study in young boys compared a booster using an antigen vaccine with a messenger RNA vaccine, and found the antigen vaccine to be more protective than the messenger RNA vaccine. From this, they conclude that there are currently data indicating there are no ongoing advantages to using these genetic vaccines. The second speaker adds that this situation is a huge mystery, questioning why the genetic RNA route was chosen in the first place. They suggest that someone made a lot of money, acknowledging that money is a factor, but saying they have never heard a scientific explanation for the decision-making process, describing it as a complete black box. They further point out that there are ongoing efforts by many people to transform vaccines beyond traditional forms to include self-replicating RNA, and that this discussion continues. They argue that the red flags from the first round have not been sorted out, and that there is no evidence these approaches are better; in fact, they imply they are clearly not better.